GR3018889T3 - Use of phospholipids for the manufacture of a topical medicament for modifying serum cholesterol levels - Google Patents

Use of phospholipids for the manufacture of a topical medicament for modifying serum cholesterol levels

Info

Publication number
GR3018889T3
GR3018889T3 GR960400284T GR960400284T GR3018889T3 GR 3018889 T3 GR3018889 T3 GR 3018889T3 GR 960400284 T GR960400284 T GR 960400284T GR 960400284 T GR960400284 T GR 960400284T GR 3018889 T3 GR3018889 T3 GR 3018889T3
Authority
GR
Greece
Prior art keywords
cholesterol levels
serum cholesterol
phospholipids
manufacture
topical medicament
Prior art date
Application number
GR960400284T
Other languages
English (en)
Inventor
Sung Lan Hsia
Jin Lin He
Original Assignee
Univ Miami
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Miami filed Critical Univ Miami
Priority claimed from PCT/US1996/001117 external-priority patent/WO1997028806A1/en
Publication of GR3018889T3 publication Critical patent/GR3018889T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Photolithography (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
GR960400284T 1990-07-30 1996-02-01 Use of phospholipids for the manufacture of a topical medicament for modifying serum cholesterol levels GR3018889T3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US07/559,932 US5231090A (en) 1990-07-30 1990-07-30 Treatment for hypercholesterolemia
PCT/US1991/005267 WO1992002226A1 (en) 1990-07-30 1991-07-30 Treatment for hypercholesterolemia
PCT/US1996/001117 WO1997028806A1 (en) 1993-04-23 1996-02-12 Treatment for hypercholesterolemia

Publications (1)

Publication Number Publication Date
GR3018889T3 true GR3018889T3 (en) 1996-05-31

Family

ID=26790867

Family Applications (1)

Application Number Title Priority Date Filing Date
GR960400284T GR3018889T3 (en) 1990-07-30 1996-02-01 Use of phospholipids for the manufacture of a topical medicament for modifying serum cholesterol levels

Country Status (11)

Country Link
US (1) US5231090A (el)
EP (1) EP0542864B1 (el)
JP (1) JP3061415B2 (el)
AT (1) ATE132040T1 (el)
AU (1) AU648482B2 (el)
CA (1) CA2088254C (el)
DE (1) DE69115909T2 (el)
DK (1) DK0542864T3 (el)
ES (1) ES2081488T3 (el)
GR (1) GR3018889T3 (el)
WO (1) WO1992002226A1 (el)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5498607A (en) * 1990-07-30 1996-03-12 University Of Miami Treatment for hypercholesterolemia
TW252918B (el) * 1993-03-31 1995-08-01 Senju Pharma Co
US5746223A (en) 1996-10-11 1998-05-05 Williams; Kevin Jon Method of forcing the reverse transport of cholesterol from a body part to the liver while avoiding harmful disruptions of hepatic cholesterol homeostasis
US6139871A (en) * 1995-07-26 2000-10-31 The University Of British Columbia Liposome compositions and methods for the treatment of atherosclerosis
US6312719B1 (en) * 1994-03-04 2001-11-06 The University Of British Columbia Liposome compositions and methods for the treatment of atherosclerosis
US6773719B2 (en) 1994-03-04 2004-08-10 Esperion Luv Development, Inc. Liposomal compositions, and methods of using liposomal compositions to treat dislipidemias
US5656284A (en) * 1995-04-24 1997-08-12 Balkin; Michael S. Oral transmucosal delivery tablet and method of making it
US5709878A (en) * 1996-08-02 1998-01-20 Rosenbaum; Jerry Transdermal delivery of dehydroepiandrosterone
US8039026B1 (en) 1997-07-28 2011-10-18 Johnson & Johnson Consumer Companies, Inc Methods for treating skin pigmentation
US5869090A (en) * 1998-01-20 1999-02-09 Rosenbaum; Jerry Transdermal delivery of dehydroepiandrosterone
US8093293B2 (en) 1998-07-06 2012-01-10 Johnson & Johnson Consumer Companies, Inc. Methods for treating skin conditions
US8106094B2 (en) 1998-07-06 2012-01-31 Johnson & Johnson Consumer Companies, Inc. Compositions and methods for treating skin conditions
US6750229B2 (en) 1998-07-06 2004-06-15 Johnson & Johnson Consumer Companies, Inc. Methods for treating skin pigmentation
US7985404B1 (en) 1999-07-27 2011-07-26 Johnson & Johnson Consumer Companies, Inc. Reducing hair growth, hair follicle and hair shaft size and hair pigmentation
US7309688B2 (en) * 2000-10-27 2007-12-18 Johnson & Johnson Consumer Companies Topical anti-cancer compositions and methods of use thereof
GB0004686D0 (en) * 2000-02-28 2000-04-19 Aventis Pharma Ltd Chemical compounds
US7250304B2 (en) * 2000-03-31 2007-07-31 The Regents Of The University Of California Functional assay of high-density lipoprotein
US20030040505A1 (en) * 2000-03-31 2003-02-27 The Regents Of The University Of California Synthetic phospholipids to ameliorate atherosclerosis and other inflammatory conditions
US6828306B2 (en) * 2000-07-31 2004-12-07 Ottawa Heart Institute Research Corporation Charged lipid compositions and methods for their use
TWI281407B (en) 2000-09-18 2007-05-21 Vasogen Ireland Ltd Apoptosis-mimicking synthetic entities and use thereof in medical treatment
CA2319928A1 (en) * 2000-09-18 2002-03-18 Vasogen Ireland Limited Apoptosis-mimicking synthetic entities and use thereof in medical treatments
US8431550B2 (en) 2000-10-27 2013-04-30 Johnson & Johnson Consumer Companies, Inc. Topical anti-cancer compositions and methods of use thereof
US7192615B2 (en) 2001-02-28 2007-03-20 J&J Consumer Companies, Inc. Compositions containing legume products
US6555143B2 (en) 2001-02-28 2003-04-29 Johnson & Johnson Consumer Products, Inc. Legume products
MXPA04002847A (es) * 2001-09-28 2004-07-05 Esperion Therapeutics Inc Metodo y aparato para la extrusion de vesiculas a presion alta.
US20040009216A1 (en) * 2002-04-05 2004-01-15 Rodrigueza Wendi V. Compositions and methods for dosing liposomes of certain sizes to treat or prevent disease
DE602004020316D1 (de) * 2003-01-20 2009-05-14 Tno Die verwendung von sphingolipiden zur senkung der cholesterin- und triglyzeridspiegel im plasma.
US8206750B2 (en) * 2005-03-24 2012-06-26 Cerenis Therapeutics Holding S.A. Charged lipoprotein complexes and their uses
US20080207503A1 (en) * 2005-06-22 2008-08-28 Chung Byung-Hong Composition and Treatment Methods for Coronary Artery Disease
DE102007051339A1 (de) * 2007-10-26 2009-04-30 Müller-Enoch, Dieter, Prof. Dr. Verwendung von Verbindungen der Formel A-R-X oder deren pharmazeutisch akzeptablen Salze zur Herstellung einer pharmazeutischen Zubereitung zur Behandlung und zur Vorbeugung von Dyslipidämien
ITPD20100130A1 (it) * 2010-04-28 2011-10-29 Antonio Gambino Prodotto anti ipercolesterolemico

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3203862A (en) * 1960-03-11 1965-08-31 Jones John Harris Oral anti-hypercholesterol composition
US3197371A (en) * 1962-07-06 1965-07-27 Armour Pharma Process for treating hypercholesteralemia
JPS55115820A (en) * 1979-02-27 1980-09-06 Nippon Shoji Kk High-purity phospholipid capsule preparation
JPS5838215A (ja) * 1981-09-01 1983-03-05 Shigeru Tokiwa コレステロールの低下剤
SU1183118A1 (ru) * 1983-10-26 1985-10-07 2-Й Московский Ордена Ленина Государственный Медицинский Институт Им.Н.И.Пирогова Способ получени экстрагента холестерина
JPS6097916A (ja) * 1983-11-01 1985-05-31 Ajinomoto Co Inc コレステロ−ル低下又は上昇抑制作用を有する組成物
JPS60214864A (ja) * 1984-04-09 1985-10-28 Hohnen Oil Co Ltd 栄養補助食品
IT1176916B (it) * 1984-10-10 1987-08-18 Elvira Pistolesi Composizione farmaceutica o dietetica ad elevata attivita' antitrombotica e antiarteriosclerotica
NO862999L (no) * 1985-07-26 1987-01-27 Yeda Res & Dev Lipidblanding for membranfluidisering.
DE4018767A1 (de) * 1990-06-12 1991-12-19 Braun Melsungen Ag Wirkstofffreie liposomen zur behandlung von atherosklerose
EP0582061A1 (de) * 1992-06-17 1994-02-09 Siemens Aktiengesellschaft Kohärent optische Vielkanalanordnung

Also Published As

Publication number Publication date
ATE132040T1 (de) 1996-01-15
DE69115909D1 (de) 1996-02-08
EP0542864A1 (en) 1993-05-26
CA2088254A1 (en) 1992-01-31
DK0542864T3 (da) 1996-05-13
ES2081488T3 (es) 1996-03-16
JPH06501245A (ja) 1994-02-10
CA2088254C (en) 2003-05-20
EP0542864A4 (en) 1993-06-30
EP0542864B1 (en) 1995-12-27
WO1992002226A1 (en) 1992-02-20
JP3061415B2 (ja) 2000-07-10
AU648482B2 (en) 1994-04-21
US5231090A (en) 1993-07-27
AU8428491A (en) 1992-03-02
DE69115909T2 (de) 1996-05-23

Similar Documents

Publication Publication Date Title
GR3018889T3 (en) Use of phospholipids for the manufacture of a topical medicament for modifying serum cholesterol levels
EP0391905A4 (en) Hemorrhoidal, other compositions and methods of treatment
JPS5791915A (en) Novel lipid composition useful for dietetics, resuscitation and treatment
EP1555025A3 (en) Use of dehydroepiandrosterone analogs for the treatment of asthma
LV12603A (en) Method of treating hyperproliferative vascular disease using rapamycin eventually in combination with mycophenolic acid
WO2000059487A3 (en) Flupirtine in the treatment of fibromyalgia and related conditions
AU1352188A (en) Mixtures for treating hypercholesterolemia
AU4492489A (en) Glucan dietary additives
CA2289717A1 (en) Novel therapy for constipation
PT880350E (pt) Tratamento de esclerose multipla
NO882635L (no) Fremgangsmaate for fremstilling av proteiner i aktive former.
BG101392A (en) Method of treating diabetes mellitus using kgf
AU6681790A (en) Method and composition for treating inflammatory bowel disorders
DE68912195D1 (de) Verwendung von Pyrrolicloncarbonsäurealkylestern zur Herstellung eines Arzneimittels zur Behandlung von Ichtyosis.
BR9003839A (pt) Processo para a remocao de tracos de contaminantes especificamente fosfolipideos e ions metalicos associados de esteres graxos,e processo de tratamento sequencial para reduzir o teor de fosfolipideos de,e descobrir esteres graxos
CA2070685A1 (en) Method for treating painful, inflammatory or allergic disorders
AU6857887A (en) Therapeutic agent
CA2144728A1 (en) Method of treating premenstrual syndrome symptomatology with vitamin d or vitamin d and calcium
ATE215810T1 (de) Abschuppungs-zusammensetzung
EP0445280A4 (en) Therapeutic agent and method of inhibiting vascularization of tumors
EP0147185A3 (en) Therapeutic use of cytidyl disphosphocholine to increase neuronal acetylcholine
HU9201045D0 (en) Combined preparation with antitrombotic effect
AU2431984A (en) Shampoo Composition of Neostigmine or Pyridostigmine
BR9907150A (pt) Métodos e kits para tratar candidìase vulvovaginal com nitrato de miconazol
AU4697979A (en) Method and compositions for reducing blood lipid concentration